Demographic features and serum CXCL13 levels of SLE patients and controls.
| SLE, N = 425 | Control, N = 106 | p | |
|---|---|---|---|
| Age, yrs, mean ± SD | 38.2 ± 12.5 | 42.13 ± 12.9 | 0.058 |
| Disease onset, yrs of age | 30.3 ± 11.2 | ||
| Disease duration, yrs | 7.8 ± 6.6 | ||
| Female/male | 15.3 (399/26) | 10.8 (97/9) | |
| Lupus nephritis | 44.23% (188/425) | ||
| Anti-dsDNA (+) antibody | 51.29% (218/425) | 0% (0/106) | |
| Serum CXCL13, pg/ml, mean ± SEM | 168.49 ± 14.49 | 107.4 ± 8.80 | < 0.001 |
| Minimum 5 | Minimum 16 | ||
| Maximum 3605 | Maximum 438 |